J
Q1 2026 13F Highlights: 5 Top Funds in 5 Minutes
15 May was the SEC 13F deadline for Q1 2026. Five top managers I think are worth a read. Here's what changed, in plain SG-investor language.
Teva Pharmaceutical Industries
TEVA----
Teva Pharmaceutical Industries (TEVA)
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the Unite...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
Teva Pharmaceutical Industries Analyst Rating
View moreForecast & Rating
Oct 28, 2026Price forecast
$47.5814.74%
Forecast & RatingStrong buy
13analysts
- Strong buy61.54%
- Buy30.77%
- Hold7.69%
- Sell0.00%
- Strong sell0.00%
News
Posts
View moreBullish vs. Bearish — Last 3 Months
1.4k followers · 0 opinions
▲Bullish50%
50%Bearish▼